Y-mAbs Therapeutics, Inc. (YMAB)
NASDAQ: YMAB · Real-Time Price · USD
8.51
0.00 (0.00%)
At close: Aug 13, 2025, 4:00 PM
8.52
+0.01 (0.12%)
Pre-market: Aug 14, 2025, 8:56 AM EDT
Y-mAbs Therapeutics Employees
Y-mAbs Therapeutics had 104 employees as of December 31, 2024. The number of employees increased by 4 or 4.00% compared to the previous year.
Employees
104
Change (1Y)
4
Growth (1Y)
4.00%
Revenue / Employee
$821,010
Profits / Employee
-$213,692
Market Cap
386.68M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
YMAB News
- 6 days ago - Y-mAbs Reports Second Quarter 2025 Financial Results and Recent Corporate Developments - GlobeNewsWire
- 6 days ago - Y-MABS THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Y-mAbs Therapeutics, Inc. - YMAB - Business Wire
- 7 days ago - Y-mAbs to Announce Second Quarter 2025 Financial and Operating Results on August 8, 2025 - GlobeNewsWire
- 9 days ago - SERB Pharmaceuticals Agrees to Acquire Y-mAbs Therapeutics - GlobeNewsWire
- 2 months ago - Y-mAbs Hosts Virtual Radiopharmaceutical R&D Update Highlighting Clinical Progress and Expanded Pipeline - GlobeNewsWire
- 2 months ago - Y-mAbs Presents GD2-SADA PRIT Trial in Progress Poster at the Advances in Neuroblastoma Research Meeting - GlobeNewsWire
- 3 months ago - Y-mAbs Therapeutics, Inc. (YMAB) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Y-mAbs to Host Virtual Radiopharmaceutical R&D Update on May 28, 2025 - GlobeNewsWire